Physician profile
Timothy D Henry
NPI 1114987997
$605,205.61
in general payments reported to CMS, 2019-2025
45 companies · $81K in 2025
The $81K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72K · 2020: $63K · 2021: $88K · 2022: $105K · 2023: $112K · 2024: $85K · 2025: $81K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $220K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Food and Beverage: $8,913 · Travel and Lodging: $5,350 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $220,025.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,155.50 |
| Food and Beverage | $8,913.08 |
| Travel and Lodging | $5,350.32 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,650.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neovasc Medical INC | $255,745.30 | 2019-2023 | |
| Shockwave Medical, INC | $169,892.63 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $51,942.60 | 2019-2025 | Coroflow Upgrade Kit, Coroflow, Pressurewire |
| Amgen INC. | $26,696.38 | 2019-2025 | Repatha, Repatha |
| Kiniksa Pharmaceuticals, Ltd. | $25,707.39 | 2021-2023 | Arcalyst |
| Zoll Circulation INC | $12,430.74 | 2022-2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Chiesi USA, INC. | $10,897.63 | 2019-2023 | Kengreal |
| Boston Scientific Corporation | $10,281.67 | 2019-2025 | Watchman Access System, Farapulse, Watchman Flx |
| Gentuity, LLC | $6,410.03 | 2023-2025 | Gentuity Hf-Oct Imaging System, Vis-Rx Prime, Vis-Rx |
| Cathworks, INC. | $5,721.18 | 2022-2025 | Ffrangio |
| Philips North America LLC | $4,350.08 | 2020-2025 | Igt Devices Undivided, (9520) Igt Devices Undivided |
| E.R. Squibb & Sons, L.L.C. | $3,620.07 | 2019 | |
| Magenta Medical INC | $3,300.00 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,813.81 | 2022-2025 | Lifevest |
| Teleflex LLC | $2,455.54 | 2022-2025 | Guideliner |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $2,367.25 | 2022 | |
| Bard Peripheral Vascular, INC. | $1,950.00 | 2024 | |
| Cook Research Incorporated | $1,800.00 | 2019 | |
| Livanova USA, INC. | $1,468.45 | 2019-2023 | Lifesparc |
| Cordis US Corp. | $1,000.00 | 2023 | Brite Tip Radianz |
| Medtronic, INC. | $694.19 | 2022-2025 | Onyx Frontier, Symplicity G3, Corevalve Evolut R |
| Medicure Pharma INC. | $500.00 | 2020 | |
| Edwards Lifesciences Corporation | $414.68 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abiomed | $406.77 | 2019-2024 | Impella |
| Medtronic Vascular, INC. | $391.64 | 2019 | |
| Cardiovascular Systems INC. | $335.62 | 2022 | |
| Heartflow, INC. | $277.88 | 2022 | |
| Corindus INC. | $206.10 | 2019 | |
| Datascope Corp. | $185.51 | 2020 | |
| Biotronik INC. | $171.78 | 2022-2023 | Recross, Pk Papyrus, Trapit |
| Kiniksa Pharmaceuticals International, Plc | $136.24 | 2024 | Arcalyst |
| Biosense Webster, INC. | $126.03 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $125.27 | 2020 | |
| Reflow Medical INC | $81.05 | 2024 | |
| Amarin Pharma, INC. | $71.11 | 2019-2020 | |
| Opsens INC. | $67.14 | 2022 | |
| Acist Medical Systems, INC. | $62.00 | 2021 | |
| Siemens Medical Solutions USA, INC. | $32.98 | 2022 | |
| Janssen Pharmaceuticals, INC | $26.09 | 2020-2022 | |
| Medline Industries Lp | $18.03 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.84 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $10.91 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$449,998.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.